Literature DB >> 21659610

Analysis of morbidity and clinical implications of laparoscopic para-aortic lymphadenectomy in a continuous series of 98 patients with advanced-stage cervical cancer and negative PET-CT imaging in the para-aortic area.

Catherine Uzan1, Amine Souadka, Sebastien Gouy, Thierry Debaere, Juliette Duclos, Jean Lumbroso, Christine Haie-Meder, Philippe Morice.   

Abstract

BACKGROUND: Laparoscopic para-aortic lymphadenectomy (PAL) is being used increasingly to stage patients with locally advanced cervical cancer (LACC) and to define radiation field limits before chemoradiation therapy (CRT). This study aimed to define clinical implications, review complications, and determine whether surgical complications delayed the start of CRT.
METHODS: We retrospectively reviewed a continuous series of patients with LACC, with no positive para-aortic (PA) nodes on positron emission tomography-computed tomography (PET-CT) and who had undergone a primary laparoscopic PAL.
RESULTS: From November 2007 to June 2010, 98 patients with LACC underwent pretherapeutic PAL. Two patients did not undergo PAL: extensive carcinomatosis was discovered in one case and a technical problem arose in the other. No perioperative complications occurred. Seven patients had a lymphocyst requiring an imaging-guided (or laparoscopic) puncture. Eight patients (8.4%, which corresponds to the false-negative PET-CT rate) had metastatic disease within PA lymph nodes. In cases of suspicious pelvic nodes on PET-CT, the risk for PA nodal disease was greater (24.0% versus 2.9%). When patients with and without surgical morbidity were compared, the median delay to the start of treatment was not significantly different (15 days; range, 3-49 days versus 18 days; range, 3-42 days).
CONCLUSIONS: The morbidity of laparoscopic PAL was limited and the completion of treatment was not delayed when complications occurred. Nevertheless, if PET-CT of the pelvic area is negative, the interest in staging PAL could be discussed because the risk for PA nodal disease is very low.

Entities:  

Mesh:

Year:  2011        PMID: 21659610      PMCID: PMC3228132          DOI: 10.1634/theoncologist.2011-0007

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  23 in total

1.  Technical development and results of left extraperitoneal laparoscopic paraaortic lymphadenectomy for cervical cancer.

Authors:  D Dargent; Y Ansquer; P Mathevet
Journal:  Gynecol Oncol       Date:  2000-04       Impact factor: 5.482

Review 2.  Is there a role for pelvic lymph node debulking in advanced cervical cancer?

Authors:  Rachel Kupets; Gillian M Thomas; Allan Covens
Journal:  Gynecol Oncol       Date:  2002-11       Impact factor: 5.482

3.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.

Authors:  Richard Pötter; Christine Haie-Meder; Erik Van Limbergen; Isabelle Barillot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Beth Erickson; Stefan Lang; An Nulens; Peter Petrow; Jason Rownd; Christian Kirisits
Journal:  Radiother Oncol       Date:  2006-01-05       Impact factor: 6.280

4.  Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.

Authors:  M A Varia; B N Bundy; G Deppe; R Mannel; H E Averette; P G Rose; P Connelly
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-12-01       Impact factor: 7.038

5.  Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.

Authors:  E Leblanc; H Gauthier; D Querleu; G Ferron; S Zerdoud; P Morice; C Uzan; S Lumbroso; F Lecuru; A S Bats; N Ghazzar; M Bannier; G Houvenaeghel; I Brenot-Rossi; F Narducci
Journal:  Ann Surg Oncol       Date:  2011-02-23       Impact factor: 5.344

6.  Lymphatic spread in stage Ib and II cervical carcinoma: anatomy and surgical implications.

Authors:  G Michel; P Morice; D Castaigne; M Leblanc; A Rey; P Duvillard
Journal:  Obstet Gynecol       Date:  1998-03       Impact factor: 7.661

7.  Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?

Authors:  Simone Marnitz; Christhardt Köhler; Christina Roth; Jürgen Füller; Wolfgang Hinkelbein; Achim Schneider
Journal:  Gynecol Oncol       Date:  2005-08-29       Impact factor: 5.482

8.  Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20.

Authors:  M Rotman; T F Pajak; K Choi; M Clery; V Marcial; P W Grigsby; J Cooper; M John
Journal:  JAMA       Date:  1995-08-02       Impact factor: 56.272

9.  Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer.

Authors:  Chyong-Huey Lai; Kuan-Gen Huang; Ji-Hong Hong; Chyi-Long Lee; Hung-Hsueh Chou; Ting-Chang Chang; Swei Hsueh; Huei-Jean Huang; Koon-Kwan Ng; Chieh-Sheng Tsai
Journal:  Gynecol Oncol       Date:  2003-04       Impact factor: 5.482

10.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

View more
  16 in total

1.  Comparison of single-port laparoscopy and conventional laparoscopy for extraperitoneal para-aortic lymphadenectomy.

Authors:  Delphine Hudry; Francesco Cannone; Gilles Houvenaeghel; Max Buttarelli; Camille Jauffret; Elisabeth Chéreau; Eric Lambaudie
Journal:  Surg Endosc       Date:  2013-06-20       Impact factor: 4.584

2.  Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy for locally advanced cervical cancer: assessment after 52 consecutive patients.

Authors:  Sébastien Gouy; Catherine Uzan; Stéphanie Scherier; Tristan Gauthier; Enrica Bentivegna; Aminata Kane; Philippe Morice; Frédéric Marchal
Journal:  Surg Endosc       Date:  2013-09-06       Impact factor: 4.584

3.  Anatomic location of PET-positive aortocaval nodes in patients with locally advanced cervical cancer: implications for surgical staging.

Authors:  Michael Frumovitz; Pedro T Ramirez; Homer A Macapinlac; Ann H Klopp; Alpa M Nick; Lois M Ramondetta; Anuja Jhingran
Journal:  Int J Gynecol Cancer       Date:  2012-09       Impact factor: 3.437

4.  Lymphocele and ovarian cancer: risk factors and impact on survival.

Authors:  Tristan Gauthier; Catherine Uzan; Delphine Lefeuvre; Aminata Kane; Geoffroy Canlorbe; Fredéric Deschamps; Catherine Lhomme; Patricia Pautier; Philippe Morice; Sébastien Gouy
Journal:  Oncologist       Date:  2012-06-15

5.  Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.

Authors:  A Martinez; M Voglimacci; A Lusque; A Ducassou; L Gladieff; N Dupuis; M A Angeles; C Martinez; Y Tanguy Le Gac; E Chantalat; A Hitzel; F Courbon; G Ferron; E Gabiache
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-08       Impact factor: 9.236

6.  Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy.

Authors:  Cyrus Chargari; Renaud Mazeron; Ariane Dunant; Sébastien Gouy; Claire Petit; Pierre Maroun; Catherine Uzan; Pierre Annede; Enrica Bentivegna; Corinne Balleyguier; Catherine Genestie; Patricia Pautier; Alexandra Leary; Catherine Lhomme; Eric Deutsch; Philippe Morice; Christine Haie-Meder
Journal:  Clin Exp Metastasis       Date:  2016-08-16       Impact factor: 5.150

7.  Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?

Authors:  Fatih Gucer; Selim Misirlioglu; Nuri Ceydeli; Cagatay Taskiran
Journal:  J Robot Surg       Date:  2017-03-02

8.  Extended field chemoradiation for cervical cancer patients with histologically proven para-aortic lymph node metastases after laparaoscopic lymphadenectomy.

Authors:  Simone Marnitz; Johanna Schram; Volker Budach; Irina Sackerer; Giuseppe Filiberto Vercellino; Jalid Sehouli; Christhardt Köhler
Journal:  Strahlenther Onkol       Date:  2014-11-21       Impact factor: 3.621

9.  Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer.

Authors:  Michael Frumovitz; Denis Querleu; Antonio Gil-Moreno; Philippe Morice; Anuja Jhingran; Mark F Munsell; Homer A Macapinlac; Eric Leblanc; Alejandra Martinez; Pedro T Ramirez
Journal:  J Minim Invasive Gynecol       Date:  2013-07-31       Impact factor: 4.137

10.  Adaptive 3D image-guided brachytherapy: a strong argument in the debate on systematic radical hysterectomy for locally advanced cervical cancer.

Authors:  Renaud Mazeron; Jennifer Gilmore; Isabelle Dumas; Jérôme Champoudry; Jennifer Goulart; Ben Vanneste; Anne Tailleur; Philippe Morice; Christine Haie-Meder
Journal:  Oncologist       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.